Identification of lncRNA NEAT1/miR‐21/RRM2 axis as a novel biomarker in breast cancer

Dongling Quan,Kai Chen,Jingru Zhang,Yiqing Guan,Danni Yang,Huanxian Wu,Shaoyu Wu,Lin Lv
DOI: https://doi.org/10.1002/jcp.29225
2019-10-17
Journal of Cellular Physiology
Abstract:<p>As a major disease that threatens the health of women worldwide, breast cancer (BC) lacks effective molecular markers in the clinic at the same time. We aim at finding a new biomarker of BC. In our study, through the Gene Expression Omnibus database chip, a total of 1393 pairs of microRNA‐messenger RNA (miRNA‐mRNA) networks and 35754 pairs of long noncoding RNA‐miRNA networks were obtained. We found out that NEAT1/miR‐21/RRM2 axis may play a role in BC diagnosis and prognosis. The real‐time quantitative reverse transcription‐polymerase chain reaction test was used to analyze the mRNA level of NEAT1, miR‐21, and RRM2. Western blot was used to detect the protein level of RRM2. Through the 5‐ethynyl‐2′‐deoxyuridine assay, the proliferation of MDA‐MB‐231 cells was detected. Through wound healing and transwell assay, the migration of MDA‐MB‐231 cells was detected. Altogether, our data indicated that NEAT1, miR‐21, and RRM2 were upregulated in several BC cell lines. Overexpressed of miR‐21 in MDA‐MB‐231 cells promote proliferation and migration. Besides, our results demonstrated that overexpressed of miR‐21 upregulated the level of RRM2. Accordingly, miR‐21/RRM2 might be a new diagnosis and treatment target of BC.</p>
cell biology,physiology
What problem does this paper attempt to address?